Medication for Alzheimer’s Disease and Associated Fall Hazard: A Retrospective Cohort Study from the Alzheimer’s Disease Neuroimaging Initiative

被引：0
|
作者：
Noam U. Epstein
Rong Guo
Martin R. Farlow
Jaswinder P. Singh
Morris Fisher
机构：
[1] Hines VA Medical Center,Department of Neurology
[2] Loyola University School of Medicine,Department of Neurology
[3] Loyola University Chicago,Office of Research Services, Health Sciences Division
[4] Indiana University School of Medicine,Indiana Alzheimer Disease Center
[5] Indiana University School of Medicine,Department of Neurology
来源：
Drugs & Aging | 2014年 / 31卷
关键词：
Mild Cognitive Impairment; Memantine; Rivastigmine; Galantamine; Allele Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：125 / 129
页数：4
相关论文
共 50 条
  • [21] Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort
    Shpanskaya, Katie S.
    Choudhury, Kingshuk Roy
    Hostage, Christopher, Jr.
    Murphy, Kelly R.
    Petrella, Jeffrey R.
    Doraiswamy, P. Murali
    JOURNAL OF NEURORADIOLOGY, 2014, 41 (05) : 350 - 357
  • [22] Differences in Medication Use in the Alzheimer's Disease Neuroimaging Initiative Analysis of Baseline Characteristics
    Epstein, Noam U.
    Saykin, Andrew J.
    Risacher, Shannon L.
    Gao, Sujuan
    Farlow, Martin R.
    DRUGS & AGING, 2010, 27 (08) : 677 - 686
  • [23] Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
    Veitch, Dallas P.
    Weiner, Michael W.
    Aisen, Paul S.
    Beckett, Laurel A.
    Cairns, Nigel J.
    Green, Robert C.
    Harvey, Danielle
    Jack, Clifford R., Jr.
    Jagust, William
    Morris, John C.
    Petersen, Ronald C.
    Saykin, Andrew J.
    Shaw, Leslie M.
    Toga, Arthur W.
    Trojanowski, John Q.
    Aisen, Paul
    Weiner, Michael
    Petersen, Ronald
    Trojanowki, John Q.
    Toga, Arthur W.
    Beckett, Laurel
    Morris, John
    Khachaturian, Zaven
    Sorensen, Greg
    Carrillo, Maria
    Kuller, Lew
    Raichle, Marc
    Paul, Steven
    Davies, Peter
    Fillit, Howard
    Hefti, Franz
    Holtzman, David
    Mesulam, M. Marcel
    Potter, William
    Snyder, Peter
    Montine, Tom
    Jimenez, Gustavo
    Donohue, Michael
    Gessert, Devon
    Harless, Kelly
    Salazar, Jennifer
    Cabrera, Yuliana
    Walter, Sarah
    Hergesheimer, Lindsey
    Harvey, Danielle
    Bernstein, Matthew
    Fox, Nick
    Thompson, Paul
    Schuff, Norbert
    DeCArli, Charles
    ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 106 - 152
  • [24] Timing of Alzheimer's disease biomarker progressions: A two-decade observational study from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
    Schaap, Tamar
    Thropp, Pamela
    Tosun, Duygu
    ALZHEIMERS & DEMENTIA, 2024, 20 (12) : 9060 - 9067
  • [25] Gray and White Matter Atrophy in Alzheimer's Disease: A Comparative Study Using Subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
    Nikelski, Jim
    Chertkow, Howard
    Evans, Alan
    NEUROLOGY, 2009, 72 (11) : A92 - A92
  • [26] The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
    Veitch, Dallas P.
    Weiner, Michael W.
    Miller, Melanie
    Ashford, Miriam A.
    Aisen, Paul S.
    Beckett, Laurel A.
    Green, Robert C.
    Harvey, Danielle
    Jack Jr, Clifford R.
    Jagust, William
    Landau, Susan M.
    Morris, John C.
    Nho, Kwangsik T.
    Nosheny, Rachel
    Okonkwo, Ozioma
    Perrin, Richard J.
    Petersen, Ronald C.
    Rivera Mindt, Monica
    Saykin, Andrew
    Shaw, Leslie M.
    Toga, Arthur W.
    Tosun, Duygu
    ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 652 - 694
  • [27] Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative
    Fowler, Mackenzie E.
    Triebel, Kristen L.
    Cutter, Gary R.
    Schneider, Lon S.
    Kennedy, Richard E.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (02) : 691 - 701
  • [28] Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants
    Groechel, Renee C.
    Tripodis, Yorghos
    Alosco, Michael L.
    Mez, Jesse
    Qiu, Wei Qiao
    Goldstein, Lee
    Budson, Andrew E.
    Kowall, Neil W.
    Shaw, Leslie M.
    Weiner, Michael
    Jack, Clifford R., Jr.
    Killiany, R. J.
    NEUROBIOLOGY OF AGING, 2023, 131 : 144 - 152
  • [29] Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative
    Dunk, Michelle M.
    Driscoll, Ira
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 85 (04) : 1519 - 1528
  • [30] Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
    Veitch, Dallas P.
    Weiner, Michael W.
    Aisen, Paul S.
    Beckett, Laurel A.
    DeCarli, Charles
    Green, Robert C.
    Harvey, Danielle
    Jack, Clifford R., Jr.
    Jagust, William
    Landau, Susan M.
    Morris, John C.
    Okonkwo, Ozioma
    Perrin, Richard J.
    Petersen, Ronald C.
    Rivera-Mindt, Monica
    Saykin, Andrew J.
    Shaw, Leslie M.
    Toga, Arthur W.
    Tosun, Duygu
    Trojanowski, John Q.
    ALZHEIMERS & DEMENTIA, 2022, 18 (04) : 824 - 857
12345